Unlocking Circularity in Biopharma: From Biohazard Waste to Resource

• Replacing carbon-intensive disposal pathways with circular treatment models to reduce Scope 3 emissions associated with biohazardous waste streams
• Recovering high-value polymer materials from single-use bioprocessing equipment including bioreactors and depth filters to advance circularity goals
• Comparing traditional thermal destruction against non-thermal treatment approaches to quantify emissions reductions, material recovery opportunities, and sustainability impact

Speakers:

Paul Coyne

Chief Commercial Officer (Cco)

Envetec Sustainable Technologies